Back

Impact of cardiovascular-kidney-metabolic conditions on clinical outcomes in patients with atrial fibrillation: results from a prospective cohort

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation epidemiology (2) Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Marco Vitolo

Modena Polyclinic Modena University Hospital, Modena (Italy)

5 More presentations in this session

Presentation thumbnail
Multimodal deep learning for near term prediction of new onset atrial fibrillation in hospitalized patients
Mr A. Mann (Himachal Pradesh, IN)
Abstract Slides Video
Presentation thumbnail
Predicting atrial fibrillation in the real world: head-to-head comparison of five risk scores
Doctor A. Estrada-Magana (Bronx, US)
Abstract Slides Video
Presentation thumbnail
Rural-urban disparities in atrial fibrillation-related diagnostic testing and medical procedures in Canada
Doctor M. Shurrab (Sudbury, CA)
Abstract Slides Video
Presentation thumbnail
Mutual reinforcement of device detected atrial fibrillation and sleep apnea
Doctor P. Spitaler (Innsbruck, AT)
Abstract Slides Video
Presentation thumbnail
The interplay between total and left atrial pericardial fat and atrial fibrillation: a systematic review and meta-analysis of their associations with AF onset, duration, recurrence, and postoperative
Mr W. Kociemba (Warsaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation epidemiology (2)

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Cardiovascular-kidney-metabolic syndrome and atrial fibrillation: insights from two real-world prospective registries across europe and east asia
thumbnail
Congress Presentation
Prognostic impact of cardiovascular-kidney-metabolic overlap among patients with acute heart failure: insights from a real-world multinational cohort
thumbnail
Congress Session
Integrated management of atrial fibrillation: addressing comorbidities, risk factors, and lifestyle

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources